Did you miss any important news last month? Check out our top 5 most popular articles from May.
The US Food and Drug Administration announced approval of Semintra—the first FDA-approved drug to control systemic hypertension in cats.
Mirataz, a transdermal ointment for the management of weight loss in cats, has recently been approved by the US Food and Drug Administration’s Center for Veterinary Medicine.
Neurosurgeons from the University of Alabama at Birmingham are partnering with veterinary universities to conduct the first immunotherapy study for brain tumors in dogs using an oncolytic herpes simplex virus.
Recent study findings show that this popular pain reliever offers no improvement over placebo treatment for elbow and stifle joint pain.
In a recent study, incorporating fecal transplantation with standard supportive care decreased mortality rate and hospitalization time for dogs with parvovirus.